List of works - Kylie D. Mason

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

scientific article

Autoreactive T cells induce necrosis and not BCL-2-regulated or death receptor-mediated apoptosis or RIPK3-dependent necroptosis of transplanted islets in a mouse model of type 1 diabetes.

scientific article published on 10 October 2014

BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs

scientific article

Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets

scientific article

Disseminated toxoplasmosis after allogeneic stem cell transplantation in a seronegative recipient

scientific article published on 20 December 2012

Go with the flow for monitoring response in myeloma with minimal residual disease

scientific article published on 01 February 2008

In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas

scholarly article

Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation

scientific article published in February 2012

Low adhesion receptor levels on circulating platelets in patients with lymphoproliferative diseases before receiving Navitoclax (ABT-263).

scientific article published in February 2013

Marked eosinophilia with abnormal basophilic granules in acute graft-versus-host disease post-allogeneic haemopoietic stem cell transplant for acute myeloid leukaemia without CBFB-MYH11 mutation.

scientific article published on 19 December 2012

Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets

scientific article

Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non-apoptotic caspase-8 is required for inflammasome priming

scientific article

Pharmacological blockade of Bcl-2, Bcl-x(L) and Bcl-w by the BH3 mimetic ABT-737 has only minor impact on tumour development in p53-deficient mice.

scientific article published on 14 October 2011

Proapoptotic Bak and Bax guard against fatal systemic and organ-specific autoimmune disease

scientific article published on 24 January 2013

Programmed anuclear cell death delimits platelet life span.

scientific article

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

scientific article published on November 2006

The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis?

scientific article

Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function.

scientific article published on 22 April 2009

List of works by Kylie D. Mason

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

Autoreactive T cells induce necrosis and not BCL-2-regulated or death receptor-mediated apoptosis or RIPK3-dependent necroptosis of transplanted islets in a mouse model of type 1 diabetes.

BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs

Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets

Disseminated toxoplasmosis after allogeneic stem cell transplantation in a seronegative recipient

Go with the flow for monitoring response in myeloma with minimal residual disease

In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas

Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation

Low adhesion receptor levels on circulating platelets in patients with lymphoproliferative diseases before receiving Navitoclax (ABT-263).

Marked eosinophilia with abnormal basophilic granules in acute graft-versus-host disease post-allogeneic haemopoietic stem cell transplant for acute myeloid leukaemia without CBFB-MYH11 mutation.

Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets

Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non-apoptotic caspase-8 is required for inflammasome priming

Pharmacological blockade of Bcl-2, Bcl-x(L) and Bcl-w by the BH3 mimetic ABT-737 has only minor impact on tumour development in p53-deficient mice.

Proapoptotic Bak and Bax guard against fatal systemic and organ-specific autoimmune disease

Programmed anuclear cell death delimits platelet life span.

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis?

Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function.